Yang Chun-Hui, Tian Xin, Yin Hai-Bin, Gao Xiao-Hui, Li Na
From the Dali University, Dali (C-HY, X-HG); Department of Hematology and Oncology, Children's Hospital of Kunming Medical University (XT, NL); and Kunming Medical University, Kunming, Yunnan, PR China (H-BY).
Medicine (Baltimore). 2015 Jan;94(1):e361. doi: 10.1097/MD.0000000000000361.
In this study, we tried to find a safe as well as fast effective treatment for sedation and analgesia for intrathecal injection in childhood leukemia patients, relieving treatment difficulties and pain, increasing the success rate of single intrathecal injection.The patients were divided into the experimental group (fentanyl combined with etomidate) and the control group (lidocaine only) randomly. The experimental group was given fentanyl 1 to 2 μg/kg intravenously first, then etomidate 0.1 to 0.3 mg/kg intravenously after the pipe washed. The patients younger than 1.5 years or who did not achieve satisfied sedative and analgesic situation received an additional time of etomidate (0.1-0.3 mg/kg). The patients were given oxygen at the rate of 4-5 L/min during the whole operation, and the finger pulse oximeter was used simultaneously to detect the changes in heart rate (HR) and blood oxygen saturation (SpO2). The doctors who performed the procedures assessed the quality of sedation and analgesia.In the experimental group, the patients' HR increased slightly after given fentanyl combined with etomidate. The patients' SpO2 was stable. Most patients achieved a good sedative and analgesic state within 1 to 2 minutes, and no case of respiration depression or cardiac arrhythmias occurred during the whole operation. The wake-up time was 55.42 ± 20.62 min. In the control group, the patients were not very cooperative during the intrathecal injection, which made the procedures very difficult.During intrathecal injection, pain obviously reduced and the success rate of single lumbar puncture increased. It is safe and effective to apply fentanyl combined with etomidate for sedation and analgesia.
在本研究中,我们试图为儿童白血病患者鞘内注射寻找一种安全且快速有效的镇静镇痛治疗方法,以缓解治疗困难和疼痛,提高单次鞘内注射的成功率。将患者随机分为实验组(芬太尼联合依托咪酯)和对照组(仅利多卡因)。实验组先静脉注射芬太尼1至2μg/kg,然后在冲管后静脉注射依托咪酯0.1至0.3mg/kg。1.5岁以下或镇静镇痛效果不满意的患者额外追加一次依托咪酯(0.1 - 0.3mg/kg)。整个手术过程中以4 - 5L/min的速率给患者吸氧,同时使用手指脉搏血氧仪检测心率(HR)和血氧饱和度(SpO2)的变化。实施操作的医生评估镇静镇痛质量。在实验组中,患者给予芬太尼联合依托咪酯后HR略有升高,SpO2稳定。大多数患者在1至2分钟内达到良好的镇静镇痛状态,整个手术过程中未发生呼吸抑制或心律失常病例。苏醒时间为55.42±20.62分钟。在对照组中,患者在鞘内注射过程中不太配合,导致操作非常困难。鞘内注射时疼痛明显减轻,单次腰椎穿刺成功率提高。应用芬太尼联合依托咪酯进行镇静镇痛安全有效。